Asymptomatic detection of SARS‐CoV‐2 among cancer patients receiving infusional anti‐cancer therapy

BACKGROUND: Little is known regarding the rate and clinical outcomes of asymptomatic carriers of SARS‐CoV‐2 among patients with cancer. Detection of asymptomatic carriers is important in this population given the use of myelosuppressive and immunomodulating therapies. Understanding the asymptomatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaya, Justin, Cabal, Angelo, Nonato, Taylor, Torriani, Francesca, Califano, Joseph, Lippman, Scott, Sacco, Assuntina, McKay, Rana R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646446/
https://www.ncbi.nlm.nih.gov/pubmed/34708934
http://dx.doi.org/10.1002/cam4.4373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646446/
https://www.ncbi.nlm.nih.gov/pubmed/34708934
http://dx.doi.org/10.1002/cam4.4373

Ejemplares similares